assay: brightfield microscopy organ: bone marrow tissue: bone marrow species: Homo sapiens studyId: syn51133946 dataType: image diagnosis: JMML studyName: DHART SPORE Project 3 Phase 1 - A High Content Clinical Trial of the MEK Inhibitor Trametinib in Juvenile Myelomonocytic Leukemia (JMML) studySite: UCSF tumorType: Juvenile Myelomonocytic Leukemia accessType: PRIVATE fileFormat: jpg initiative: Developmental and HyperActive Ras Tumor Specialized Programs of Research Excellence isCellLine: No specimenID: left bone marrow bioopsy dataSubtype: raw individualID: 870851 resourceType: experimentalData fundingAgency: NIH-NCI isMultiSpecimen: No isMultiIndividual: No experimentalCondition: Pre-trial baseline